CARE-DNA Aps
APSActiveAdvertising protectionCVR 44184729Gammel Kalkbrænderi Vej 8, 2100 København ØManufacture of medical and dental instruments and supplies· NACE 3250Est. 2023 · 3 years old— employees
Loading company…
Overview
CARE-DNA Aps is a Danish APS based in København Ø, operating in the Manufacture of medical and dental instruments and supplies sector. Incorporated in 2023, the company reported a gross profit of -DKK 20.3k in its latest annual filing.
Gross profit 2025
-20.3K DKK
+392% vs 2024
EBITDA margin (of gross profit)
100.0 %
−392% vs 2024
Net profit 2025
-20.3K DKK
-327% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
100.0 %
Very strongAmong the 10% highest rated companies in the industry
20242025
Liquidity ratioCurrent assets ÷ Short-term debt
0.0×
20242025
Return on assets (ROA)Net profit ÷ Total assets × 100
-45.2 %
Very weakAmong the 20% lowest rated companies in the industry
20242025
EBITDA — year on year
DKK thousandsKey figures
Annual report 2025| Gross profit | -20.3K DKK | +392% |
| EBITDA | -20.3K DKK | -392% |
| Net profit | -20.3K DKK | -327% |
| Total assets | 45K DKK | -33% |
| Equity | 45K DKK | -31% |
| Employees | — | — |
Company information
Legal name
CARE-DNA Aps
CVR number
44184729
Legal form
Anpartsselskab
NACE code
Founded
12 July 2023 · 3 years
Share capital
DKK 70,000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen i forening.
Company purpose
Selskabets formål er at drive virksomhed inden for medicobranchen samt enhver i forbindelse
hermed stående virksomhed
(no translation available)
Contact
Address
Gammel Kalkbrænderi Vej 8, 2100 København Ø
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), CARE-DNA Aps reported a gross profit of -DKK 20.3k. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of DKK 20.3k.
At the end of 2025, equity financed 100% of the balance sheet.
Financials
Gross profit
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2025 | 2024 |
|---|---|---|
| Gross profit | -20 | -4 |
| Staff expenses | -0 | -0 |
| EBITDA | -20 | -4 |
| Depreciation & amort. | -0 | -0 |
| EBIT | -20 | -4 |
| Net financials | 0 | -0 |
| Profit before tax | -20 | -4 |
| Tax | -0 | 1 |
| Net profit | -20 | -5 |
Balance sheet
DKK thousands| Item | 2025 | 2024 |
|---|---|---|
| Total assets | 45 | 67 |
| Equity | 45 | 65 |
| Long-term debt | 0 | 0 |
| Short-term debt | 0 | 1 |
| Total debt | 0 | 1 |
Financial ratios
5-year trendEBITDA margin (of gross profit)
<−999 %
20242025
Equity ratio
100.0 %
Very strongAmong the 10% highest rated companies in the industry
20242025
Return on equity
-45.2 %
Very weakAmong the 20% lowest rated companies in the industry
20242025
Net profit margin (of gross profit)
<−999 %
20242025
Asset turnover (of gross profit)
-0.45×
20242025
Debt / equity
0.00×
20242025
Sector performance
14 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 20% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current assets to equityStrong
Among the 30% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 40% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Debt & solvency
Solidity ratioVery strong
Among the 10% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Liabilities to equityVery strong
Among the 10% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Interest rate on debtVery strong
Among the 10% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 20% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Income to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Efficiency & development
Equity to contributed capitalWeak
Among the 30% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityVery weak
Among the 20% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery strong
Among the 10% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Asset turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
BR Management | Management | 2023 |
SA Management | Management | 2023 |
PC Founder | Founder | 2023 |
DB Founder | Founder | 2023 |
JW Founder | Founder | 2023 |
Former (1)
JL Management | Management | 2023 – 2024 |
Board of directors
Non-executive oversightNo data on file.
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 90–99.99% | 90–99.99% | 2024 | |
| Company | 90–99.99% | 90–99.99% | 2023 | |
| Individual | 5–9.99% | 5–9.99% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Related companies
Company hierarchy
Phi Diagnostics ApS
CARE-DNA Aps Board network connections
Board members of CARE-DNA Aps also hold positions in 11 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sefa Alizadeh | Management | 3 companies |
| Birgitte Regenberg | Management | 2 companies |
| Paul Christian Bartling | Founder | 2 companies |
| Jessica Lehd Lauesen | Management | 2 companies |
| David Bjerre Bjørklund | Founder | 1 company |
| Johan Wilhelm Bartling | Founder | 1 company |
Frequently asked questions
What is the CVR number of CARE-DNA Aps?
CARE-DNA Aps is registered with CVR / Virk under CVR 44184729.
What is the gross profit of CARE-DNA Aps?
CARE-DNA Aps reported a gross profit of -DKK 20.3k in 2025.
Where is CARE-DNA Aps headquartered?
CARE-DNA Aps's registered address is Gammel Kalkbrænderi Vej 8, 3. tv.